Charles Schwab’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Sell |
118,606
-46,764
| -28% | -$144K | ﹤0.01% | 3256 |
|
|
2025
Q1 | $319K | Sell |
165,370
-4,410
| -3% | -$8.51K | ﹤0.01% | 3193 |
|
|
2024
Q4 | $635K | Buy |
169,780
+3,145
| +2% | +$11.8K | ﹤0.01% | 3069 |
|
|
2024
Q3 | $815K | Buy |
166,635
+41,558
| +33% | +$203K | ﹤0.01% | 2985 |
|
|
2024
Q2 | $938K | Buy |
125,077
+40,197
| +47% | +$301K | ﹤0.01% | 2959 |
|
|
2024
Q1 | $2.11M | Buy |
+84,880
| New | +$2.11M | ﹤0.01% | 2578 |
|